Effect of Endothelin-A Receptor Blockade With Atrasentan on Tumor Progression in Men With Hormone-Refractory Prostate Cancer: A Randomized, Phase II, Placebo-Controlled Trial Purpose: To investigate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback